Pharmaceutical Industry in the
Canton of Neuchâtel

Celgene R&D Sàrl

Since 2007 · 1–10 empl.·4.0(69)

Celgene R&D Sàrl is part of Bristol Myers Squibb and focuses on the research, development, and provision of medicines. Its activities include biopharmaceutical research, clinical studies, and the production of medicines for serious diseases in areas such as oncology, hematology, immunology, and cardiovascular disease.

Baxalta Manufacturing Sàrl

Since 2003 · 101–500 empl.

Baxalta Manufacturing Sàrl is listed on Takeda's website as a company associated with the Takeda production site. The production site manufactures biotechnologically produced medicines for bleeding disorders, including recombinant factor VIII and recombinant von Willebrand factor.

GMT Fine Chemicals SA

Since 1997 · 11–20 empl.·4.2(5)

The core activity of GMT Fine Chemicals SA is the production of therapeutically active substances, in particular reduced folates, which are used in the manufacture of pharmaceuticals, primarily in oncology and gynecology.

CCBD Sàrl

Since 2021 · 1–10 empl.

CCBD Sàrl is a producer of CBD products, particularly CBD-containing cannabis grown indoors using state-of-the-art technology and in compliance with good manufacturing practices (CGMP). The company's core activity encompasses the cultivation, production, and distribution of CBD products such as flowers, oils, extracts, and other CBD-containing articles.

Sintetica SA

Since 2022 · 21–50 empl.·4.0(6)

Sintetica SA develops and manufactures sterile liquid injectable medicines and related pharmaceutical products, focusing on anaesthesia, pain management, intensive care and neuromodulation. The company operates production lines for ampoules, vials and infusion bags and pursues innovation through its Swiss Innovation Laboratory.

Active-Food SA

Since 2011 · 11–20 empl.·3.6(9)

The core activity of Active-Food Suisse is the development, manufacture and production of dietary supplements, vitamins, plant extracts, minerals and other nutritional products. The company also offers services such as research and development, quality control, production and distribution. It focuses on producing high-quality products that meet Swiss quality standards.

NUTRAPHAR SA

Since 2022 · 11–20 empl.

The core activity of Nutraphar is the development and provision of innovative solutions in the pharmaceutical industry, particularly in the areas of biotechnology, vaccines and nanostructured materials.

B SQUARED Sàrl

Since 2023 · 1–10 empl.

The core activity of B Squared SARL is to provide services to the life sciences industry, particularly in the areas of: bioprocess development and optimization, process modeling and software training, outsourcing and supply chain solutions, and consulting and support for the development and implementation of cell and gene therapies. The company supports customers in the development and implementation of innovative therapies and offers comprehensive services in the areas of research and development, manufacturing, quality assurance and operations.

Apolab SA

Since 2024 · 1–10 empl.

The core activity of Apolab is the manufacture of high-quality preparations, in particular magistral formulas and formula officinalis, ranging from simple to complex preparations, including medications, cosmetics and dietary supplements. The company produces sterile and non-sterile preparations in small quantities and also offers individually tailored preparations upon request.

LN Laboratoire Nutraceutical SA

Since 2025 · 1–10 empl.

LN Laboratoire Nutraceutical SA develops and sells food supplements, in particular the Vitae Complex® formula. The company states that its products are formulated, produced and controlled in Switzerland, and that they use natural ingredients together with a patented microencapsulation technology.

Corena Therapeutics Sàrl

Since 2020 · 1–10 empl.

Corena Therapeutics Sàrl develops, manufactures and distributes products and services for the healthcare and pharmaceutical sectors. Its activities focus on skin care and dermatology products, high-quality biocides, commercial pharmaceutical products, and sourcing and supply solutions for clinical trials.

Phytolabo Sàrl

Since 2023 · 1–10 empl.

Phytolabo Sàrl produces homeopathic and plant‑based preparations for healthcare professionals, including Hahnemannian and Korsakovian granules, spagyries, mother tinctures, standardized plant extracts, Bach flower remedies and oligoelements. The laboratory is Swissmedic‑approved and applies pharmaceutical quality and traceability controls.